Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 063947/0039 | |
| Pages: | 12 |
| | Recorded: | 06/14/2023 | | |
| Attorney Dkt #: | XENTHERA-ASST1 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
4
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/07/2016
|
Application #:
|
14469900
|
Filing Dt:
|
08/27/2014
|
|
Publication #:
|
|
Pub Dt:
|
03/12/2015
| | | | |
|
Title:
|
Substituted 2,3-dihydro-1H-inden-1-one Retinoic acid-related orphan nuclear receptor Antagonists for Treating Multiple Sclerosis
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
09/20/2016
|
Application #:
|
15087807
|
Filing Dt:
|
03/31/2016
|
|
Publication #:
|
|
Pub Dt:
|
07/28/2016
| | | | |
|
Title:
|
Substituted 2,3-dihydro-1H-inden-1-one Retinoic acid-related orphan nuclear receptor Antagonists for Treating Multiple Sclerosis
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
01/08/2019
|
Application #:
|
15087811
|
Filing Dt:
|
03/31/2016
|
|
Publication #:
|
|
Pub Dt:
|
07/28/2016
| | | | |
|
Title:
|
Substituted 2,3-dihydro-1H-inden-1-one Retinoic acid-related orphan nuclear receptor Antagonists for Treating Multiple Sclerosis
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/16/2020
|
Application #:
|
16239869
|
Filing Dt:
|
01/04/2019
|
|
Publication #:
|
|
Pub Dt:
|
07/11/2019
| | | | |
|
Title:
|
SUBSTITUTED 2, 3-DIHYDRO-1H-INDEN-1-ONE RETINOIC ACID-RELATED ORPHAN NUCLEAR RECEPTOR ANTAGONISTS FOR TREATING MULTIPLE SCLEROSIS
|
|
|
Assignee
|
|
|
|
|
| 344 WEST 13800 SOUTH, SUITE 400 |
| DRAPER, UTAH 84020 |
|
|
Correspondence name and address
|
| |
BRADLEY B JENSEN
|
| |
344 WEST 13800 SOUTH, SUITE 400
|
| |
DRAPER, UT 84020
|
Search Results as of:
05/02/2024 06:04 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
